Topic Highlight
Copyright ©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Oct 14, 2014; 20(38): 13705-13717
Published online Oct 14, 2014. doi: 10.3748/wjg.v20.i38.13705
Figure 11
Figure 11 Representative Western blot analysis of 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase-3, inducible 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase-3, 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase-4, and hypoxia inducible factor-1α protein levels in breast, lung, colon, and stomach malignant tumors (T) and non-malignant (control) tissues counterparts (N) from same patients. The actin was used to ensure equal loading of the sample[30,32,33]. HIF: Hypoxia inducible factor; PFKFB: 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase.